122. Is life science adopting AI? copertina

122. Is life science adopting AI?

122. Is life science adopting AI?

Ascolta gratuitamente

Vedi i dettagli del titolo

Offerte di stagione | 0,99 €/mese per i primi 3 mesi

A seguire 9,99 €/mese – si applicano condizioni. Puoi disdire mensilmente.

AI is moving fast — but is life science actually adopting it?

In this episode of Discovery Matters, we explore how artificial intelligence is being used across pharma and life sciences, and where progress is still cautious. Joined by Joe Luminiello, CEO of RCG Intel, we discuss the balance between speed and safety, innovation and regulation, and why human context still matters as much as algorithms.

Cutting through the hype, this conversation asks not just whether the industry should use AI — but how to do it thoughtfully.

adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione